Potential Risks and Rewards With Prophylaxis for Clostridium difficile Infection

被引：12

作者：

Johnson, Stuart ^{[1
,2
]}

机构：

[1] Loyola Univ, Chicago Stritch Sch Med, Maywood, IL 60153 USA

[2] Hines Vet Affairs Hosp, Hines, IL USA

来源：

CLINICAL INFECTIOUS DISEASES | 2016年 / 63卷 / 05期

关键词：

prophylaxis; Clostridium difficile; CDI; VANCOMYCIN; FIDAXOMICIN; RECURRENCE; MICROBIOTA;

D O I：

10.1093/cid/ciw424

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：654 / 655

页数：2

共 12 条

[1] Defining the Vulnerable Period for Re-Establishment of Clostridium difficile Colonization after Treatment of C. difficile Infection with Oral Vancomycin or Metronidazole [J].

Abujamel, Turki ;

Cadnum, Jennifer L. ;

Jury, Lucy A. ;

Sunkesula, Venkata C. K. ;

Kundrapu, Sirisha ;

Jump, Robin L. ;

Stintzi, Alain C. ;

Donskey, Curtis J. .

PLOS ONE, 2013, 8 (10)

[2] Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) [J].

Cohen, Stuart H. ;

Gerding, Dale N. ;

Johnson, Stuart ;

Kelly, Ciaran P. ;

Loo, Vivian G. ;

McDonald, L. Clifford ;

Pepin, Jacques ;

Wilcox, Mark H. .

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (05) :431-455

[3] The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing [J].

Dethlefsen, Les ;

Huse, Sue ;

Sogin, Mitchell L. ;

Relman, David A. .

PLOS BIOLOGY, 2008, 6 (11) :2383-2400

[4] Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy [J].

Edlund, C ;

Barkholt, L ;

OlssonLiljequist, B ;

Nord, CE .

CLINICAL INFECTIOUS DISEASES, 1997, 25 (03) :729-732

[5] Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial Management [J].

Eyre, David W. ;

Walker, Sarah ;

Wyllie, David ;

Dingle, Kate E. ;

Griffiths, David ;

Finney, John ;

O'Connor, Lily ;

Vaughan, Alison ;

Crook, Derrick W. ;

Wilcox, Mark H. ;

Peto, Timothy E. A. .

CLINICAL INFECTIOUS DISEASES, 2012, 55 :S77-S87

[6] TREATMENT OF ASYMPTOMATIC CLOSTRIDIUM-DIFFICILE CARRIERS (FECAL EXCRETORS) WITH VANCOMYCIN OR METRONIDAZOLE - A RANDOMIZED, PLACEBO-CONTROLLED TRIAL [J].

JOHNSON, S ;

HOMANN, SR ;

BETTIN, KM ;

QUICK, JN ;

CLABOTS, CR ;

PETERSON, LR ;

GERDING, DN .

ANNALS OF INTERNAL MEDICINE, 1992, 117 (04) :297-302

[7] Loss of Microbiota-Mediated Colonization Resistance to Clostridium difficile Infection With Oral Vancomycin Compared With Metronidazole [J].

Lewis, Brittany B. ;

Buffie, Charlie G. ;

Carter, Rebecca A. ;

Leiner, Ingrid ;

Toussaint, Nora C. ;

Miller, Liza C. ;

Gobourne, Asia ;

Ling, Lilan ;

Pamer, Eric G. .

JOURNAL OF INFECTIOUS DISEASES, 2015, 212 (10) :1656-1665

[8] Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI [J].

Louie, Thomas J. ;

Cannon, Kris ;

Byrne, Brendan ;

Emery, Judy ;

Ward, Linda ;

Eyben, Melissa ;

Krulicki, Walter .

CLINICAL INFECTIOUS DISEASES, 2012, 55 :S132-S142

[9] Outcomes of Deflect-1: A Multicenter, Blinded, Randomized Clinical Trial of Fidaxomicin (FDX) Vs. Placebo (PLC) for Prophylaxis of Clostridium Difficile Associated Diarrhea (CDAD) in Subjects Undergoing Hematopoietic Stem Cell Transplantation (HSCT) [J].

Mullane, Kathleen M. ;

Adachi, Javier ;

Dubberke, Erik ;

Alexander, Barbara ;

Broyde, Natasha ;

Sears, Pamela .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) :S171-S171

[10] Efficacy of Fidaxomicin Versus Vancomycin as Therapy for Clostridium difficile Infection in Individuals Taking Concomitant Antibiotics for Other Concurrent Infections [J].

Mullane, Kathleen M. ;

Miller, Mark A. ;

Weiss, Karl ;

Lentnek, Arnold ;

Golan, Yoav ;

Sears, Pamela S. ;

Shue, Youe-Kong ;

Louie, Thomas J. ;

Gorbach, Sherwood L. .

CLINICAL INFECTIOUS DISEASES, 2011, 53 (05) :440-447

← 1 2 →